Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Glatiramer Acetate injection bulk supplier for pharma manufacturers

Glatiramer Acetate Injection 20 mg/mL, 40 mg/mL Suppliers & Bulk Manufacturers

Available Forms: SQ injection

Available Strengths: 20 mg/mL, 40 mg/mL

Reference Brands: Copaxone(US)

Category: Multiple sclerosis

Glatiramer Acetate modulates the immune system by shifting T-cell responses from pro-inflammatory to anti-inflammatory, reducing autoimmune attack on the nervous system. It decreases relapse frequency, slows disease progression, and minimizes lesion development in multiple sclerosis. Benefits include improved symptom control, fewer relapses, and enhanced quality of life for MS patients.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Glatiramer Acetate, marketed as Copaxone, is approved in the US by the FDA and in the EU via EMA for multiple sclerosis. Regulatory approval requires a detailed dossier including clinical efficacy, safety data, manufacturing quality, and pharmacovigilance plans. In the US, the FDA reviews comprehensive clinical and manufacturing details, while the EMA ensures compliance with regional safety and quality standards.

Glatiramer Acetate Injection — third party manufacturing & bulk supply

Glatiramer Acetate Injection 20 mg/mL, 40 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Indicative minimum order quantity

Glatiramer Acetate Injection is supplied as SQ injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Glatiramer Acetate Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Glatiramer Acetate Injection →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Glatiramer Acetate injection is listed as SQ injection in 20 mg/mL, 40 mg/mL. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Glatiramer Acetate injection is referenced against Copaxone(US). Reference brands are shown for identification only and remain the property of their respective trademark owners.

Glatiramer Acetate injection is catalogued under Multiple sclerosis on PharmaTradz. Related products within the same category are listed at the foot of this page.

Submit an RFQ stating your destination market, required quantity and whether you need stock supply, third party manufacturing or dossier licensing. Matched suppliers respond with pricing, MOQ and lead times.

Related Products

Lamotriginevdispersible Tablets

Strength:
XR: 25 mg, 50 mg, 100 mg, 200 mg; IR: 25 mg, 100 mg, 200 mg, 300 mg

Form: Tablets(IR & ER)

Reference Brands: Lamictal, Lamictal XR(EU & US)

View Details
Dalfampridine

Strength:
10 mg

Form: Extended-Release tablets (XR)

Reference Brands: Ampyra(US)

View Details
Tizanidine Tablets/Capsules

Strength:
2 mg and 4 mg

Form: Oral Capsules/Tablets

Reference Brands: Zanaflex (US)

View Details
Baclofen Tablets:

Strength:
10 mg and 20 mg

Form: Tablet

Reference Brands: Lioresal, Gablofen(US & EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.